Citi Downgrades Puma Biotechnology (PBYI) to Neutral
Tweet
Share
E-mail
Get Alerts PBYI Hot Sheet
Price: $7.56 +4.56%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz downgraded Puma Biotechnology (NASDAQ: PBYI) from Buy to Neutral with a price target of $24.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $19.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CLSA Downgrades Subaru Corp. (7270:JP) (FUJHY) to Outperform (2)
- Berenberg Downgrades Anglo American Plc. (AAL:LN) (NGLOY) to Hold
- Axis Capital Limited Downgrades Nippon Life India Asset Management Ltd (NAM:IN) to Add (2)
Create E-mail Alert Related Categories
DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
